4
Changes in Ownership
MBX Biosciences, Inc. Filed Acc 0000950170-24-107524
Director bought 750,000 shares at $16.00 ($12,000,000)
- Director acquired 3,062,215 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GORDON CARL L Director | 2024-09-16 | Conversion | +2,658,428 | 2,658,428 | I | ||
| GORDON CARL L Director | 2024-09-16 | Conversion | +403,787 | 403,787 | I | ||
| GORDON CARL L Director | 2024-09-16 | Purchase | +500,000 | $16.00 | $8,000,000 | 3,158,428 | I |
| GORDON CARL L Director | 2024-09-16 | Purchase | +250,000 | $16.00 | $4,000,000 | 653,787 | I |
| Derivatives | |||||||
| GORDON CARL L Director | 2024-09-16 | Conversion · Series A Convertible Preferred Stock | −12,372,634 | 0 | I | ||
| GORDON CARL L Director | 2024-09-16 | Conversion · Series B Convertible Preferred Stock | −19,587,284 | 0 | I | ||
| GORDON CARL L Director | 2024-09-16 | Conversion · Series C Convertible Preferred Stock | −4,854,368 | 0 | I | ||
| Open-market purchases · 750,000 sh · avg $16.00 · $12,000,000 | |||||||
Loading xslF345X05/ownership.xml…